NSRX
Nasus Pharma Ltd
AMEX · Pharmaceuticals
$5.44
-0.36 (-6.21%)
Stocks Under $10
Pharmaceutical Stocks
Healthcare Stocks
Best Dividend Stocks
Highest Dividend Yield
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.90M | 15.57M | 15.33M |
| Net Income | 2.99M | 2.88M | 3.11M |
| EPS | — | — | — |
| Profit Margin | 17.7% | 18.5% | 20.3% |
| Rev Growth | +19.1% | +9.8% | -6.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 8.79M | 9.10M | 10.20M |
| Total Equity | 24.63M | 26.89M | 27.54M |
| D/E Ratio | 0.36 | 0.34 | 0.37 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 3.97M | 4.34M | 3.61M |
| Free Cash Flow | 3.54M | 3.27M | 3.55M |